New hip stem could mean better bone preservation for younger patients

NCT ID NCT07600632

Recruiting now Disease control Sponsor: Istituto Ortopedico Rizzoli Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well a short, bone-friendly stem works for total hip replacement when done through a front-of-hip incision. Researchers will follow 400 adults with hip arthritis for at least two years to check implant survival, complications, pain, and recovery. The goal is to see if this stem design helps preserve bone and improves outcomes, especially for younger and more active people.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: short femoral stem implant (cementless, hydroxyapatite-coated)
What this could lead to: If successful, this could confirm that short stems are a safe and effective option for hip replacement, especially for younger, active patients, potentially preserving bone and improving recovery.
What could go wrong: This is an observational study, not a randomized trial, so results may be less definitive. Previous reports have shown mixed outcomes, including implant loosening or bone changes, particularly in active patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIP ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis, hip osteonecrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIP ARTHRITIS

Contacts and locations

Locations

IRCCS Istituto Ortopedico Rizzoli
RECRUITING

Bologna, 40136, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.